尋找研究成果

搜尋結果

• 評論/辯論

  Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: Identification of functional disparities between azacytidine and decitabine [Oncotarget. 7, (2016), 27363-27378] doi 10.18632/oncotarget.8455

  Hsieh, Y. Y., Huang, T. C., Lo, H. L., Jhan, J. Y., Chen, S. T. & Yang, P. M., 5月 10 2016, 於: Oncotarget. 9, 64, p. 32402 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Determinants of physical activity: A path model based on an ecological model of active living (PLoS ONE (2019) 14:7 (e0220314) DOI: 10.1371/journal.pone.0220314)

  Yen, H. Y. & Li, C., 1月 1 2019, 於: PLoS ONE. 14, 9, e0222625.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Correction: Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation (PLoS ONE (2013) 8:4 (e61939) DOI: 10.1371/journal.pone.0061939)

  Lee, Y. L., Chen, C. W., Liu, F. H., Huang, Y. W. & Huang, H. M., 10月 2017, 於: PLoS ONE. 12, 10, e0186528.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Sex differences in fracture outcomes within Taiwan population: A nationwide matched study (PLoS ONE (2020) 15:4 (e0231374) DOI: 10.1371/journal.pone.0231374)

  Chou, F. P., Chang, H. C., Yeh, C. C., Wu, C. H., Cherng, Y. G., Chen, T. L. & Liao, C. C., 5月 2020, 於: PLoS ONE. 15, 5, p. e0234229 e0234229.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction: Effects of collagen matrix and bioreactor cultivation on cartilage regeneration of a full-thickness critical-size knee joint cartilage defects with subchondral bone damage in a rabbit model (PLoS One (2018) 13:5 (e0196779) DOI: 10.1371/journal.pone.0196779)

  Wang, K. H., Wan, R., Chiu, L. H., Tsai, Y. H., Fang, C. L., Bowley, J. F., Chen, K. C., Shih, H. N. & Thomas Lai, W. F., 6月 1 2018, 於: PLoS One. 13, 6, e0199567.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  4 引文 斯高帕斯（Scopus）

• Correction: Benzoflavone derivatives as potent antihyperuricemic agents(MedChemCommun (2019) DOI: 10.1039/c8md00512e)

  Singh, J. V., Mal, G., Kaur, G., Gupta, M. K., Singh, A. P., Nepali, K., Singh, H., Sharma, S. & Bedi, P. M. S., 1月 1 2019, 於: MedChemComm. 10, 1, 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  1 引文 斯高帕斯（Scopus）

• Correction: MPT0B169, a new antitubulin agent, inhibits Bcr-Abl expression and induces mitochondrion-mediated apoptosis in nonresistant and imatinib-resistant chronic myeloid leukemia cells (PLoS ONE (2016) 11:1 (e0148093) DOI: 10.1371/journal.pone.0148093)

  Wong, S. M., Liu, F. H., Lee, Y. L. & Huang, H. M., 10月 2017, 於: PLoS ONE. 12, 10, e0186531.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  1 引文 斯高帕斯（Scopus）

• Correction: Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin(PLoS ONE (2018) 13:2 (e0192632) DOI: 10.1371/journal.pone.0192632)

  Lee, S. P., Kao, C. Y., Chang, S. C., Chiu, Y. L., Chen, Y. J., Chen, M. H. G., Chang, C. C., Lin, Y. W., Chiang, C. P., Wang, J. K., Lin, C. Y. & Johnson, M. D., 5月 1 2018, 於: PLoS One. 13, 5, e0198569.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction: Formation and characterization of the high precision nanoscale thin film resistors on radio frequency application [Int. J. Electrochem. Sci., 10 (2015) (6517-6526)]

  Huang, H. Y., Wu, C-Y. & Wu, C. C., 6月 1 2018, 於: International Journal of Electrochemical Science. 13, 6, p. 6155 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Evaluation of a novel biodegradable thermosensitive keto-hydrogel for improving postoperative pain in a rat model (PLoS ONE (2017) 12:10 (e0186784) DOI: 10.1371/journal.pone.0186784)

  Wu, M. H., Shih, M. H., Hsu, W. B., Dubey, N. K., Lee, W. F., Lin, T. Y., Hsieh, M. Y., Chen, C. F., Peng, K. T., Huang, T. J., Shi, C. S., Guo, R. S., Cai, C. J., Chung, C. Y. & Wong, C. H., 11月 1 2018, 於: PLoS ONE. 13, 11, e0203372.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction: Inflammation promotes expression of stemness-related properties in hbv-related hepatocellular carcinoma (PLoS ONE (2016)11:2 (e0149897) DOI: 10.1371/journal.pone.0149897)

  Chang, T. S., Chen, C. L., Wu, Y. C., Liu, J. J., Kuo, Y. C., Lee, K. F., Lin, S. Y., Lin, S. E., Tung, S. Y., Kuo, L. M., Tsai, Y. H. & Huang, Y. H., 1月 1 2017, 於: PLoS One. 12, 1, e0171176.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Hou et al. Emerging role of vitamins D and K in modulating uremic vascular calcification: The aspect of passive calcification. (Nutrients (2019), 11(1), 152, 10.3390/nu11010152)

  Hou, Y. C., Lu, C. L., Zheng, C. M., Chen, R. M., Lin, Y. F., Liu, W. C., Yen, T. H., Chen, R. & Lu, K. C., 3月 1 2019, 於: Nutrients. 11, 3, 567.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Correction: De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells [Oncotarget. 5, 21, (2014) (10558-70)] doi: 10.18632/oncotarget.2510.

  Chang, Y. W., Chen, H. A., Tseng, C. F., Hong, C. C., Ma, J. T., Hung, M. C., Wu, C. H., Huang, M. T. & Su, J. L., 2016, 於: Oncotarget. 7, 48, p. 80101 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells (Oncogenesis, (2017), 6, 7, (e359), 10.1038/oncsis.2017.61)

  Huang, H. L., Wu, H. Y., Chu, P. C., Lai, I. L., Huang, P. H., Kulp, S. K., Pan, S. L., Teng, C. M. & Chen, C. S., 2月 1 2020, 於: Oncogenesis. 9, 2, 27.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction: Soluble AXL: A possible circulating biomarker for neurofibromatosis type 1 related tumor burden

  Johansson, G., Peng, P. C., Huang, P. Y., Chien, H. F., Hua, K. T., Kuo, M. L. & Chen, C. T., 3月 17 2015, 於: PLoS One. 10, 3, e0119975.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Extended visible to near-infrared harvesting of earth-abundant FeS₂-TiO₂ heterostructures for highly active photocatalytic hydrogen evolution (Green Chemistry (2018) 20 (1640-1647) DOI: 10.1039/C7GC03173D)

  Kuo, T. R., Liao, H. J., Chen, Y. T., Wei, C. Y., Chang, C. C., Chen, Y. C., Chang, Y. H., Lin, J. C., Lee, Y. C., Wen, C. Y., Li, S. S., Lin, K. H. & Wang, D. Y., 1月 1 2018, 於: Green Chemistry. 20, 11, 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  1 引文 斯高帕斯（Scopus）

• Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling (Oncogene, (2019), 38, 8, (1340-1353), 10.1038/s41388-018-0497-4)

  Pai, V. C., Hsu, C. C., Chan, T. S., Liao, W. Y., Chuu, C. P., Chen, W-Y., Li, C. R., Lin, C. Y., Huang, S. P., Chen, L. T. & Tsai, K. K., 2月 21 2019, 於: Oncogene. 38, 8, p. 1354 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  7 引文 斯高帕斯（Scopus）

• Correction: Chronic hepatitis C virus infection is associated with the development of rheumatoid arthritis: A nationwide population-based study in Taiwan (PLoS ONE (2014) 9:11 (e113579) DOI: 10.1371/journal.pone.0113579)

  Su, F. H., Wu, C. S., Sung, F. C., Chang, S. N., Su, C. T., Shieh, Y. H. & Yeh, C. C., 11月 1 2016, 於: PLoS One. 11, 11, e0166508.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study (PLoS One (2018) 13:10 (e0206011) DOI: 10.1371/journal.pone.0206011)

  Hsu, Y. H., Yen, Y. C., Lin, Y. C. & Sung, L. C., 4月 1 2019, 於: PLoS ONE. 14, 4, e0215546.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction: ZBTB46, SPDEF, ETV6 novel potential biomarkers and therapeutic targets in castration resistance prostate cancer (Int. j. mol. sci. (2019), 20, 2802, 10.3390/ijms20112802)

  Fararjeh, A. F. S. & Liu, Y. N., 6月 2 2020, 於: International journal of molecular sciences. 21, 12, 1 p., 4243.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer (Oncogene, (2016), 35, 12, (1517-1528), 10.1038/onc.2015.214)

  Chang, Y. W., Tseng, C. F., Wang, M. Y., Chang, W. C., Lee, C. C., Chen, L. T., Hung, M. C. & Su, J. L., 1月 23 2020, 於: Oncogene. 39, 4, p. 946-949 4 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells [Oncotarget, 7, 8, (2016) (9135-9149)] DOI: 10.18632/oncotarget.7035

  Liu, C. Y., Hu, M. H., Hsu, C. J., Huang, C. T., Wang, D. S., Tsai, W. C., Chen, Y. T., Lee, C. H., Chu, P. Y., Hsu, C. C., Chen, M. H., Shiau, C. W., Tseng, L. M. & Chen, K. F., 2017, 於: Oncotarget. 8, 6, p. 10760 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Correction: Ou et al. Bone Healing and Regeneration Potential in Rabbit Cortical Defects Using an Innovative Bioceramic Bone Graft Substitute. Appl. Sci. 2020, 10, 6239

  Ou, K. L., Hou, P. J., Huang, B. H., Chou, H. H., Yang, T. S., Huang, C. F. & Ueno, T., 1月 1 2022, 於: Applied Sciences (Switzerland). 12, 1, 446.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction: Induction of connective tissue growth factor expression by hypoxia in human lung fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 pathways (PLoS ONE (2016) 11:8 (e0160593) DOI: 10.1371/journal.pone.0160593)

  Cheng, Y., Lin, C. H., Chen, J. Y., Li, C. H., Liu, Y. T. & Chen, B. C., 11月 1 2017, 於: PLoS One. 12, 11, e0188608.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  2 引文 斯高帕斯（Scopus）

• Correction: Two Ck1δ transcripts regulated by m6A meth-ylation code for two antagonistic kinases in the control of the circadian clock (Proceedings of the National Academy of Sciences of the United States of America (2018) 115 (5980-5985) DOI: 10.1073/pnas.1721371115)

  Fustin, J. M., Kojima, R., Itoh, K., Chang, H. Y., Ye, S., Zhuang, B., Oji, A., Gibo, S., Narasimamurthy, R., Virshup, D., Kurosawa, G., Doi, M., Manabe, I., Ishihama, Y., Ikawa, M. & Okamura, H., 7月 3 2018, 於: Proceedings of the National Academy of Sciences of the United States of America. 115, 27, p. E6386

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Correction: Hepatitis C virus core protein down-regulates p21^Waf1/Cip1 and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells (PLoS ONE (2013) 8:4 (e61089) DOI: 10.1371/journal.pone.0061089)

  Shiu, T. Y., Huang, S. M., Shih, Y. L., Chu, H. C., Chang, W. K. & Hsieh, T. Y., 7月 1 2017, 於: PLoS One. 12, 7, e0181299.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  1 引文 斯高帕斯（Scopus）

• Correction: Non-invasive in vivo molecular imaging of intraarticularly transplanted immortalized bone marrow stem cells for osteoarthritis treatment [Oncotarget., 8, (2017) (97153-97164)] DOI: 10.18632/oncotarget.21315

  Peng, B. Y., Chiou, C. S., Dubey, N. K., Yu, S. H., Deng, Y. H., Tsai, F. C., Chiang, H. S., Shieh, Y. H., Chen, W. H. & Deng, W. P., 5月 18 2018, 於: Oncotarget. 9, 38, 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  1 引文 斯高帕斯（Scopus）

• Correction: Identification of putative ligand-binding sites of the integrin α4β1 (VLA-4, CD49d/CD29) (Biochemical Journal (1996) 305 (945-951))

  Kamata, T., Puzon, W. & Takada, Y., 1996, 於: Biochemical Journal. 317, 3, 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: The role of RELB [Oncotarget., 9, (2018), (7631-7643)] DOI: 10.18632/oncotarget.24146

  Feng, P. H., Yu, C. T., Chen, K. Y., Luo, C. S., Wu, S. M., Liu, C. Y., Kuo, L. W., Chan, Y. F., Chen, T. T., Chang, C. C., Lee, C. N., Chuang, H. C., Lin, C. F., Han, C. L., Lee, W. H. & Lee, K. Y., 7月 31 2018, 於: Oncotarget. 9, 59, p. 31559 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma (Oncotarget (2017) 8 (7489-7501) DOI: 10.18632/oncotarget.9841)

  Wang, L. T., Chiou, S. S., Chai, C. Y., Hsi, E., Wang, S. N., Huang, S. K. & Hsu, S. H., 12月 1 2018, 於: Oncotarget. 9, 102, p. 37807 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy(PLoS ONE (2015) 10:3 (e0121207) 10.1371/journal.pone.0121207)

  Lee, Y. H., Liu, X., Qiu, F., O'Connor, T. R., Yen, Y. & Ann, D. K., 4月 13 2015, 於: PLoS ONE. 10, 4, 0124853.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  2 引文 斯高帕斯（Scopus）

• Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

  Siu, M. K., Abou-Kheir, W., Yin, J. J., Chang, Y. S., Barrett, B., Suau, F., Casey, O., Chen, W. Y., Fang, L., Hynes, P., Hsieh, Y. Y., Liu, Y. N., Huang, J. & Kelly, K., 8月 17 2018, 於: Oncotarget. 9, 64, p. 32403 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
  3 引文 斯高帕斯（Scopus）

• Correction: Antipsychotic medications and stroke in schizophrenia: A case-crossover study(PLoS ONE (2019)12:6 (e0179424)Doi:10.1371/journal.pone.0179424)

  Chen, W. Y., Chen, L. Y., Liu, H. C., Wu, C. S., Yang, S. Y., Pan, C. H., Tsai, S. Y., Chen, C. C. & Kuo, C. J., 5月 1 2019, 於: PLoS ONE. 14, 5, e0217323.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Correction: Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities (PLoS ONE)

  Chen, Y. J., Chang, S. C., Tsao, K. C., Shih, S. R., Yang, S. L., Lin, T. Y. & Huang, Y. C., 6月 21 2013, 於: PLoS ONE. 8, 6

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction: Production and characterization of neutralizing antibodies against Bungarus multicinctus snake venom [Applied and Environmental Microbiology, 82, 23, (2016), (6973-6982)] DOI:10.1128/AEM.01876-16

  Lee, C. H., Lee, Y. C., Leu, S. J., Lin, L. T., Chiang, J. R., Hsu, W. J. & Yangd, Y. Y., 11月 1 2017, 於: Applied and Environmental Microbiology. 83, 22, e01949-17.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction to: A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer (Gastric Cancer, (2021), 24, 3, (624-639), 10.1007/s10120-020-01154-5)

  Hsu, C. C., Liao, W. Y., Chang, K. Y., Chan, T. S., Huang, P. J., Chiang, C. T., Shan, Y. S., Cheng, L. H., Liao, T. Y. & Tsai, K. K., 5月 2021, 於: Gastric Cancer. 24, 3, p. 640-641 2 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Chitosan-based hydrogels to treat hydrofluoric acid burns and prevent infection (Drug Delivery and Translational Research, (2021), 11, 4, (1532-1544), 10.1007/s13346-021-01007-3)

  Huang, S. W., Yeh, F. C., Ji, Y. R., Su, Y. F., Su, Y. S., Chiang, M. H., Tzeng, S. C., Fu, C. Y., Cheng, A., Wang, Y. C. & Lee, Y. T., 3月 2022, 於: Drug Delivery and Translational Research. 12, 3, p. 732 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: The knockdown of Neuropeptide FF receptor 2 inhibits capsaicin-induced CGRP Upregulation in mouse trigeminal ganglion (The Journal of Headache and Pain, (2020), 21, 1, (87), 10.1186/s10194-020-01152-z)

  Lin, Y. T., Yu, Z., Tsai, S. C., Hsu, P. H. & Chen, J. C., 12月 2020, 於: Journal of Headache and Pain. 21, 1, 140.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Inhaled gold nanoparticles cause cerebral edema and upregulate endothelial aquaporin 1 expression, involving caveolin 1 dependent repression of extracellular regulated protein kinase activity (Particle and Fibre Toxicology (2019) 16 (37) DOI: 10.1186/s12989-019-0324-2)

  Chen, C. Y., Liao, P. L., Tsai, C. H., Chan, Y. J., Cheng, Y. W., Hwang, L. L., Lin, K. H., Yen, T. L. & Li, C. H., 11月 18 2019, 於: Particle and Fibre Toxicology. 16, 1, 43.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）

• Correction to: Liu, h.w.; et al. enhanced hsa-mir-181d/p-stat3 and hsa-mir-181d/p-stat5a ratios mediate the anticancer effect of garcinol in stat3/5a-addicted glioblastoma. cancers 2019, 11, 1888

  Liu, H. W., Lee, P. M., Bamodu, O. A., Su, Y. K., Fong, I. H., Yeh, C-T., Chien, M-H., Kan, I-H. & Lin, C-M., 10月 2020, 於: Cancers. 12, 10, p. 1-4 4 p., 2846.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Aryl hydrocarbon receptor signaling promotes ORMDL3-dependent generation of sphingosine-1-phosphate by inhibiting sphingosine-1-phosphate lyase (Cellular & Molecular Immunology, (2018), 10.1038/s41423-018-0022-2)

  Wang, H. C., Wong, T. H., Wang, L. T., Su, H. H., Yu, H. Y., Wu, A. H., Lin, Y. C., Chen, H. L., Suen, J. L., Hsu, S. H., Chen, L. C., Zhou, Y. & Huang, S. K., 9月 1 2018, 於: Cellular and Molecular Immunology. 15, 9, p. 870 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era (Annals of Surgical Oncology, (2020), 10.1245/s10434-020-08923-7)

  Huang, T. W., Su, C. M. & Tam, K. W., 12月 2020, 於: Annals of Surgical Oncology. 27, p. 986 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Risk of adverse outcomes in patients with rheumatoid arthritis hospitalized for stroke—a cross-sectional study (Clinical Rheumatology, (2018), 37, (2917–2926), 10.1007/s10067-018-4287-8)

  Kang, J. H., Xirasagar, S., Lin, H. C., Kao, P. F. & Sung, L. C., 5月 1 2019, 於: Clinical Rheumatology. 38, 5, p. 1533 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction to: Long-Term Oral Toxicity and Anti-osteoporotic Effect of Sintered Dicalcium Pyrophosphate in Rat Model of Postmenopausal Osteoporosis (Journal of Medical and Biological Engineering, (2017), 37, 2, (181-190), 10.1007/s40846-016-0197-x)

  Tsai, Y. F., Hsu, L. H., Wu, C. C., Cai, W. H., Yang, K. C. & Fan, F. Y., 10月 1 2020, 於: Journal of Medical and Biological Engineering. 40, 5

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Single-site laparoscopic burnia for inguinal hernias in girls: comparison with open repair (Surgical Endoscopy, (2021), 35, 1, (471-475), 10.1007/s00464-020-07983-w)

  Duh, Y. C., Chang, P. C. Y., Huang, H., Fu, Y. W., Hsu, Y. J., Wei, C. H. & Shen, M. H., 6月 2022, 於: Surgical endoscopy. 36, 6, p. 4638 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Life-Threatening Enterovirus 71 Encephalitis in Unrelated Children with Autosomal Dominant TLR3 Deficiency (Journal of Clinical Immunology, (2022), 10.1007/s10875-021-01170-9)

  Kuo, C. Y., Ku, C. L., Lim, H. K., Hsia, S. H., Lin, J. J., Lo, C. C., Ding, J. Y., Kuo, R. L., Casanova, J. L., Zhang, S. Y., Chang, L. Y. & Lin, T. Y., 2022, (接受/付印) 於: Journal of Clinical Immunology.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Total analysis of clinical factors for surgical success of adenotonsillectomy in pediatric OSAS (European Archives of Oto-Rhino-Laryngology, (2017), 274, 1, (561-566), 10.1007/s00405-016-4218-8)

  Chang, T. S. & Chiang, R. P. Y., 3月 1 2018, 於: European Archives of Oto-Rhino-Laryngology. 275, 3, p. 841 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Risk reduction of long-term major adverse cardiovascular events after endoscopic thoracic sympathectomy in palmar hyperhidrosis (Clinical Autonomic Research, (2017), 27, 6, (393-400), 10.1007/s10286-017-0464-0)

  Cheng, C. A., Cheng, C. G., Chu, H., Lin, H. C., Chung, C. H., Chiu, H. W. & Chien, W. C., 8月 1 2018, 於: Clinical Autonomic Research. 28, 4, 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Correction to: Micronized sacchachitin promotes satellite cell proliferation through TAK1-JNK-AP-1 signaling pathway predominantly by TLR2 activation (Chinese Medicine, (2020), 15, 1, (100), 10.1186/s13020-020-00381-3)

  Wu, MH. H., Lin, CY. Y., Hou, CY. Y., Sheu, MT. T. & Chang, H., 12月 2021, 於: Chinese Medicine (United Kingdom). 16, 1, 17.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取

• Correction to: Chemotherapy Immunophenoprofiles in Non-Small-Cell Lung Cancer by Personalized Membrane Proteomics (PROTEOMICS - Clinical Applications, (2018), 12, 2, (1700040), 10.1002/prca.201700040)

  Utami Putri, D., Feng, P. H., Hsu, Y. H., Lee, K. Y., Jiang, F. W., Kuo, L. W., Chen, Y. J. & Han, C. L., 3月 1 2020, 於: Proteomics - Clinical Applications. 14, 2, 1970064.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

  開啟存取